Pharmacy Market BUZZ

Market News, Products, Services, and Trends

Ensuring Safety in the Compounding Lab with ChemoAlert Surface Sampling Kit


Drug residue is an inevitable challenge in compounding labs, and preventing harmful substances from lingering on personnel is crucial for health and safety. Prolonged exposure to hazardous drugs can pose significant risks over time.


In alignment with USP 800 and NAPRA regulations, the North America Bureau Veritas has developed the ChemoAlert Surface Sampling Kit, enabling pharmacies to test for exposure to antineoplastic drugs effectively.

Inline_file-2418-1737994428.png

The ChemoAlert kit is widely used by hospitals, pharmacies, infusion centers, and others handling chemotherapy drugs across the U.S. and Canada. It contains all the essential tools to collect viable hazardous drug (HD) samples, including:

• 10 swabs

• 10 vials

• Templates

• Wetting agent

• Gloves

• Ice pack to maintain sample integrity


Each swab can detect up to 19 hazardous drugs, including platinum-based compounds. The kit is user-friendly, offering step-by-step instructions to ensure accurate sampling. Compared to similar products, ChemoAlert stands out for its superior sensitivity and specificity, making it an indispensable tool for safeguarding workplace safety.


By incorporating tools like ChemoAlert, healthcare organizations can foster a safer environment for their staff and patients alike.


Today's Posts
Subscribe



What are SPOTLIGHTS?

SPOTLIGHTS are brief introductions to companies, products, product features,
and services that could potentially benefit the pharmacy operations of RXinsider's readership.


Spotlights2.png

Suggest a SPOTLIGHT

To suggest a subject to be profiled in a SPOTLIGHT, please contact 
your RXinsider Account Manager or RXinsider's Marketing and Operations Manager, Samantha Roy.




This post is related to:

Compounding: USP <797> & <800> Sterile Resources, Compliance, Technology